Medical supervision is essential , particularly for those at risk for metabolic or oncologic conditions, and because IGF1 LR3 is banned in sports
Combination with Insulin with or without Metformin In a 26-week double blind trial (Trial 6, NCT03021187), 731 adult patients with type 2 diabetes mellitus inadequately controlled on insulin (basal, basal/bolus or premixed) with or without metformin, were randomized to semaglutide tablets 3 mg, 7 mg and 14 mg orally once daily or placebo once daily
Do not assume that because both medications are prescribed individually, they can be combined without additional consideration
Adding B12 directly to the injection bypasses this problem entirely
Dose: 50-100mcg Frequency: 1-2 times per week initially Timing: 1-3 hours before intended bedtime Duration: 2-4 week assessment period This cautious approach allows you to gauge individual response before committing to more aggressive protocols